Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MCRB Seres Therapeutics > Detailed Quotes

MCRB Seres Therapeutics

Watchlist
6.110
-0.120-1.93%
Close  12/07 16:00 ET
High
6.220
Open
6.160
Turnover
4.91M
Low
5.880
Pre Close
6.230
Volume
805.08K
Market Cap
761.26M
P/E(TTM)
Loss
52wk High
9.490
Shares
124.59M
P/E(Static)
Loss
52wk Low
2.500
Float Cap
565.34M
Bid/Ask %
0.00%
Historical High
52.000
Shs Float
92.53M
Volume Ratio
0.91
Historical Low
2.020
Dividend TTM
--
Div Yield TTM
--
P/B
11.27
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.87%
Amplitude
5.46%
Avg Price
6.100
Lot Size
1
Float Cap
565.34M
Bid/Ask %
0.00%
Historical High
52.000
Shs Float
92.53M
Volume Ratio
0.91
Historical Low
2.020
Dividend TTM
--
P/B
11.27
Dividend LFY
--
Turnover Ratio
0.87%
Amplitude
5.46%
Avg Price
6.100
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
CEO: Mr. Eric D. Shaff
Market: NASDAQ
Listing Date: 06/26/2015
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist